Lapatinib and metronomic capecitabine combination in an HER2-positive inflammatory breast cancer patient: a case report

被引：6
作者：
Montagna, E. [1 ]
Cancello, G. [1 ]
Torrisi, R. [1 ]
Rizzo, S. [2 ]
Scarano, E. [1 ]
Colleoni, M. [1 ]
机构：
[1] European Inst Oncol, Res Unit Med Senol, Dept Med, Milan, Italy
[2] European Inst Oncol, Div Diagnost Radiol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷 / 03期
关键词：
BEVACIZUMAB;
D O I：
10.1093/annonc/mdp563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：667 / U238
页数：2
相关论文
共 5 条
  • [1] Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens
    Blackwell, K. L.
    Pegram, M. D.
    Tan-Chiu, E.
    Schwartzberg, L. S.
    Arbushites, M. C.
    Maltzman, J. D.
    Forster, J. K.
    Rubin, S. D.
    Stein, S. H.
    Burstein, H. J.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (06) : 1026 - 1031
  • [2] A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
    Cameron, David
    Casey, Michelle
    Press, Michael
    Lindquist, Deborah
    Pienkowski, Tadeusz
    Romieu, C. Gilles
    Chan, Stephen
    Jagiello-Gruszfeld, Agnieszka
    Kaufman, Bella
    Crown, John
    Chan, Arlene
    Campone, Mario
    Viens, Patrice
    Davidson, Neville
    Gorbounova, Vera
    Raats, Johannes Isaac
    Skarlos, Dimosthenis
    Newstat, Beth
    Roychowdhury, Debasish
    Paoletti, Paolo
    Oliva, Cristina
    Rubin, Stephen
    Stein, Steven
    Geyer, Charles E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 112 (03) : 533 - 543
  • [3] Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer
    Dellapasqua, Silvia
    Bertolini, Francesco
    Bagnardi, Vincenzo
    Campagnoli, Elisabetta
    Scarano, Eloise
    Torrisi, Rosalba
    Shaked, Yuval
    Mancuso, Patrizia
    Goldhirsch, Aron
    Rocca, Andrea
    Pietri, Elisabetta
    Colleoni, Marco
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4899 - 4905
  • [4] Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+cohort in EGF103009, a phase II study
    Kaufman, Bella
    Trudeau, Maureen
    Awada, Ahmad
    Blackwell, Kimberly
    Bachelot, Thomas
    Salazar, Vanessa
    DeSilvio, Michelle
    Westlund, Ronald
    Zaks, Tal
    Spector, Neil
    Johnston, Stephen
    [J]. LANCET ONCOLOGY, 2009, 10 (06) : 581 - 588
  • [5] Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer
    Wedam, SB
    Low, JA
    Yang, SX
    Chow, CK
    Choyke, P
    Danforth, D
    Hewitt, SM
    Berman, A
    Steinberg, SM
    Liewehr, DJ
    Plehn, J
    Doshi, A
    Thomasson, D
    McCarthy, N
    Koeppen, H
    Sherman, M
    Zujewski, J
    Camphausen, K
    Chen, H
    Swain, SM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (05) : 769 - 777
1